MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
MRVI currently has 146M outstanding shares. with moderate dilution risk from 71.7M authorized shares representing 49.0% potential dilution. The company has diluted shareholders by 10.29% over the past 2 years through share issuances.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 08, 2026 |
10-Q filing | 146.4M shares outstanding |
150M | 72M |
| Nov 07, 2025 |
10-Q filing | 144.7M shares outstanding |
140M | 72M |
| Aug 11, 2025 |
10-Q filing | 144.2M shares outstanding |
140M | 72M |
| May 12, 2025 |
10-Q filing | 143.4M shares outstanding |
140M | 72M |
| Mar 18, 2025 |
10-K filing | 137.9M shares outstanding |
140M | 72M |
| Nov 12, 2024 |
10-Q filing | 141.6M shares outstanding |
140M | 72M |
| Aug 08, 2024 |
10-Q filing | 135.8M shares outstanding |
140M | 72M |
| May 09, 2024 |
10-Q filing | 132.3M shares outstanding |
130M | 72M |
| Feb 29, 2024 |
10-K filing | 131.9M shares outstanding |
130M | 72M |
| Nov 08, 2023 |
10-Q filing | 131.9M shares outstanding |
130M | 72M |
| Aug 08, 2023 |
10-Q filing | 131.9M shares outstanding |
130M | 72M |
| May 09, 2023 |
10-Q filing | 131.7M shares outstanding |
130M | 72M |
| Feb 28, 2023 |
10-K filing | 131.5M shares outstanding |
130M | 72M |
| Nov 04, 2022 |
10-Q filing | 131.5M shares outstanding |
130M | 72M |
| Aug 05, 2022 |
10-Q filing | 131.5M shares outstanding |
130M | 72M |
| May 06, 2022 |
10-Q filing | 131.5M shares outstanding |
130M | 72M |
| Mar 01, 2022 |
10-K filing | 131.5M shares outstanding |
130M | 72M |
| Jan 03, 2022 |
8-K filing: Maravai LifeSciences Holdings, Inc. contributed $110 million to Topco in exchange for 2,732,919 newly-issued units, and subsequently forfeited 2,732,919 Common Units to maintain a 1:1 ratio of Class A Common Stock to Common Units. ($110.0M proceeds) |
120M | 72M |
| Nov 15, 2021 |
10-Q filing | 118.4M shares outstanding |
120M | 72M |
| Sep 07, 2021 |
S-1 filing: The selling stockholders are offering 20,000,000 shares of Class A common stock. The underwriters have the option to purchase up to an additional 3,000,000 shares of Class A common stock from the selling stockholders. |
110M | 72M |
| Aug 11, 2021 |
10-Q filing | 112.3M shares outstanding |
110M | 49M |
| May 12, 2021 |
10-Q filing | 114.4M shares outstanding |
110M | 49M |
| Apr 05, 2021 |
S-1 filing: This is an S-1 filing for an offering of Class A common stock by selling stockholders, with an option for underwriters to purchase additional shares. |
N/A | 49M |
| Nov 13, 2020 |
S-1/A filing: This S-1/A filing describes a proposed offering of Class A common stock with an estimated net proceeds of $1,184.5 million, based on an assumed IPO price of $25.50 per share. The company intends to use the proceeds to acquire LLC Units in Topco LLC. |
N/A | 46M |
| Nov 09, 2020 |
S-1/A filing: This is an S-1/A filing for a common stock offering underwritten by Morgan Stanley & Co. LLC, Jefferies LLC, and Goldman Sachs & Co. LLC, including firm shares and additional shares for over-allotments. |
N/A | 0 |